Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2026 09:15 ET | Source: Robbins Geller Rudman & Dowd LLP

INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law

The case alleges Boston Scientific misled investors about its US EP segment's growth and competitive risks.
March 30, 2026 06:12 ET | Source: Robbins Geller Rudman & Dowd LLP

INVESTOR ALERT: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law

The case alleges Boston Scientific misled investors about its US EP segment's growth and competitive risks.
March 25, 2026 09:35 ET | Source: Robbins Geller Rudman & Dowd LLP

BSX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

The case alleges Boston Scientific misled investors about its US EP segment's growth and competitive risks.
March 22, 2026 16:00 ET | Source: Robbins Geller Rudman & Dowd LLP

BSX INVESTOR ALERT: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law

The case alleges Boston Scientific misled investors about its US EP segment's growth and competitive risks.
March 18, 2026 14:15 ET | Source: Robbins Geller Rudman & Dowd LLP

INVESTOR ALERT: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law

The case alleges Boston Scientific misled investors about its US EP segment's growth and competitive risks.
March 14, 2026 12:10 ET | Source: Robbins Geller Rudman & Dowd LLP

INVESTOR DEADLINE: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law

The case alleges Boston Scientific misled investors about its US EP segment's growth and competitive risks.
March 10, 2026 14:40 ET | Source: Robbins Geller Rudman & Dowd LLP

INVESTOR ALERT: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead the Boston Scientific Class Action Lawsuit – RGRD Law

The case alleges Boston Scientific misled investors about its US EP segment's growth and competitive risks.
March 10, 2026 09:08 ET | Source: Grabar Law Office

Important Notice to Long-Term Shareholders of Boston Scientific Corporation (NYSE: BSX): Corcept Therapeutics, Inc. (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR): and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

Notice Shareholders of Boston Scientific (NYSE: BSX): Corcept Therapeutics (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR); and Unicycive (NASDAQ: UNCY)
January 28, 2021 08:00 ET | Source: Portnoy Law

Boston Scientific Corporation Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm

Investors with losses are encouraged to contact the firm before February 3, 2021; click here to submit trade information LOS ANGELES, Jan. 28, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises...
January 20, 2021 19:22 ET | Source: Portnoy Law

Portnoy Law: Lawsuit Filed On Behalf of Boston Scientific Corporation Investors

Click here to join the case LOS ANGELES, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Boston Scientific...